What is Boston Scientific known for?
- 1 What is Boston Scientific known for?
- 2 Is Boston Scientific a big company?
- 3 Is Boston Scientific being bought out?
- 4 What is a Boston Scientific device?
- 5 Is Boston Scientific a reputable company?
- 6 Is Boston Scientific a good place to work?
- 7 Does Abbott own Boston Scientific?
- 8 How many companies has Boston Scientific acquired?
- 9 How many products does Boston Scientific have?
- 10 Can a pacemaker be adjusted remotely?
- 11 What does Boston Scientific do?
- 12 Is Boston Scientific Corporation an equal opportunity employer?
- 13 Does Boston Scientific own Rubicon Medical Corporation?
- 14 Does Boston Scientific own Advanced Bionics?
Boston Scientific is primarily known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries.
Is Boston Scientific a big company?
Forbes and Just Capital have released their 2020 list of America’s top 100 JUST companies, and Boston Scientific ranked 28 overall, second among companies in the healthcare equipment and services industry, and number one for workers.
Is Boston Scientific being bought out?
The deal announced Tuesday is expected to close in the fourth quarter of 2021. Boston Scientific has been a strategic investor in Devoro since 2019, holding an equity stake of approximately 16%. The acquisition will give Boston Scientific the remaining 84% stake.
What is a Boston Scientific device?
Boston Scientific ICD and S-ICD systems are designed to monitor and treat abnormally fast ventricular heart rhythms by delivering electrical energy to the heart. Find out how they work, what to expect after your procedure, and how to lead a full and active life with an implanted device.
Is Boston Scientific a reputable company?
“Overall good researching company.” “I’ve worked for Boston Scientific since 2019. They strive to make a positive impact in patient lives to meet customer demands. Boston Scientific is a wonderful company to work for, they invest in their employees development and it’s a wonderful work environment.
Is Boston Scientific a good place to work?
Boston Scientific ranked 35 in Glassdoor’s U.S. large company category with an overall company rating of 4.4 out of 5.0.
Does Abbott own Boston Scientific?
Under its agreement with Abbott, Boston Scientific will receive $6.4 billion in cash from Abbott on or around the closing date of the Guidant transaction.
How many companies has Boston Scientific acquired?
List of Boston Scientific’s 49 Acquisitions, including Baylis Medical Company And DeVoro Medical | Crunchbase.
How many products does Boston Scientific have?
Boston Scientific is a Massachusetts-based company that manufactures products for various medical uses. By 2017, the company had developed more than 13,000 medical products marketed in 100 countries around the world.
Can a pacemaker be adjusted remotely?
You may have an assessment using a monitor and telephone line or an internet connection on a periodic basis. Most current ICDs and some pacemakers can now be followed remotely. This means the device can wirelessly transmit data to your doctor.
What does Boston Scientific do?
- Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world. Professionals.
Is Boston Scientific Corporation an equal opportunity employer?
- Boston Scientific Corporation has been and will continue to be an equal opportunity employer. To ensure full implementation of its equal employment policy, the Company will continue to take steps to assure that recruitment, hiring, assignment, promotion, compensation, and all other personnel decisions are made…
Does Boston Scientific own Rubicon Medical Corporation?
- In June Boston Scientific announced that its wholly owned subsidiary, Nemo I Acquisition, Inc., had successfully acquired Rubicon Medical Corporation, with Rubicon became a wholly owned subsidiary of Boston Scientific.
Does Boston Scientific own Advanced Bionics?
- In June Boston acquired Advanced Bionics Corporation for $740 million in cash, plus earn out payments. In December Boston completed its acquisition of Advanced Stent Technologies, Inc. for $120 million payable in Boston Scientific stock, plus the possibility of future contingent payments.